Daniel joined SEP in 2021 and is based in SEP's London office. He works principally on identifying, executing and managing growth stage technology investments.

He was a key member of the deal teams which led SEP’s investments into accounts payable automation software company Springtime, drug discovery and design software vendor Cresset, and business process orchestration software provider, Enate.

Daniel joined SEP from global private markets investment firm StepStone Group, where he was a member of the EMEA Private Equity team. Prior to that, Daniel began his career in Investment Banking at Goldman Sachs in London, where he worked on a range of transactions for high growth, technology-enabled, corporate clients.

He is a graduate of the University of Bath and holds a BEng (Hons) in Chemical Engineering.

‍